Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Agios, Ascendis, Elevar, Haemonetics, Medibeacon, Oculis, Polypid, Praxis, Sanofi, Scholar Rock.
Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: Cytovale, Fortress, Infinimmune, Leo, Lipella, Merck & Co., Mindmaze, Novo, Poxel, Scynexis, Takeda, Vibra.
New hires and promotions in the biopharma and med-tech industries, including: Immunic, Inogen, Kalohexis, Onconetix, Proxygen, Reset Health, Science Corp., Stryker, Telo Genomics.
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: 4DMedical, Anumana, Biogen, Boston Scientific, Bridgebio, Butterfly, Chiesi, Egetis, Eisai,Elevar, GSK, Merck, Nanoscope, Roche, Savara, SS Innovations, Sobi, Teva, Zymeworks.
Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: AP Biosciences, Aurinia, Biocytogen, Enodia, Everest Medicines, J&J, Kezar, Konica Minolta, Radiant Vision, Royalty Pharma, Taisho, Tasly.
Clinical updates for biopharma and med tech, including data readouts and publications: Alumis, Arcutis, Arrowhead, Biogen, Boston Scientific, BMS, Castle, Cathworks, Connect, Idorsia, Incyte, Inflarx, Innovent, Johnson & Johnson, Kardigan, Kymera, Levicept, Medtronic, Moonlake, Pie Medical, Priovant, Sanofi, Simcere, Takeda, United, Viridian.
Biopharma and med-tech companies raising money in public or private financings, including: 4DMedical, Alamar, Anaptysbio,Arch, Artelo, Centivax, First Tracks, Kailera, Oncomatryx.